Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
Alana M. Harris
Overview
Structured Data
Issues
Contributors
Activity
All edits
Edits on 9 Nov, 2022
"update inverses"
Golden AI
edited on 9 Nov, 2022
Edits made to:
Infobox
(
+1
properties)
Infobox
Author of
Let 'Em Have It
Edits on 4 Sep, 2022
"update inverses"
Golden AI
edited on 4 Sep, 2022
Edits made to:
Infobox
(
+1
properties)
Infobox
Author of
The Matinee Idol
Edits on 15 Dec, 2021
"Remove inverse infobox"
Golden AI
edited on 15 Dec, 2021
Edits made to:
Infobox
(
-161
properties)
Infobox
Patent primary examiner of
US Patent 7090983 Methods for detecting early cancer
US Patent 7091039 Kunitz domain polypeptide zkun6
US Patent 7097966 Detection of survivin in the biological fluids of cancer patients
US Patent 7108986 Glypican-1 in human breast cancer
US Patent 7118924 Method for producing human antibodies in SCID mice which uses dendritic cells pulsed with antigen-antibody complexes and antigen-antibody complexes as immunizing agents
US Patent 7119171 Binding polypeptides
US Patent 7122635 Method and composition for angiogenesis inhibition
US Patent 7122653 Reagents and methods useful for detecting diseases of the prostate
US Patent 7135549 Nucleic acid and corresponding protein entitled 184P1E2 useful in treatment and detection of cancer
US Patent 7144704 Methods and reagents for preparing and using immunological agents specific for P-glycoprotein
US Patent 7153661 Artificial antibody polypeptides
US Patent 7157556 Deglycosylated kringle 1-3 region fragments of plasminogen and methods of use
US Patent 7176020 EBV-infected stomach cancer cell line
US Patent 7195868 Compositions and methods for the identification, assessment, prevention, and therapy of human cancers
US Patent 7199231 Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-4 and 41 and uses thereof
US Patent 7217533 P38 MAPK pathway predicts endocrine-resistant growth of human breast cancer and provides a novel diagnostic and treatment target
US Patent 7226992 Mutant Bcl-2 proteins and uses thereof
US Patent 7241576 Uses of THANK, a TNF homologue that activates apoptosis
US Patent RE39789 Tumor therapy
US Patent 7268207 Gene differentially expressed in breast and bladder cancer, and encoded polypeptides
US Patent 7270980 Compounds for immunodiagnosis of prostate cancer and methods for their use
US Patent 7271240 125P5C8: a tissue specific protein highly expressed in various cancers
US Patent 7273924 Antibodies to the ED-B domain of fibronectin, their construction and uses
US Patent 7276581 Mutated Src oncogene composition and methods
US Patent 7276595 DNA sequence encoding a retinoic acid regulated protein
US Patent 7282207 Reagents and methods useful for detecting diseases of the reproductive tissues
US Patent 7282346 Methods for cancer prognosis and diagnosis
US Patent 7291462 TADG-15: an extracellular serine protease overexpressed in carcinomas
US Patent 7297760 Cancer associated protein
US Patent 7301016 Human transferase family members and uses thereof
US Patent 7306910 Breast cancer prognostics
US Patent 7319134 Regulation of transcription factor, NF-IL6/LAP
US Patent 7335467 Breast cancer antigens
US Patent 7342108 De novo DNA cytosine methyltransferase genes, polypeptides and uses thereof
US Patent 7342109 Human kinase interacting protein 2 (KIP2)-related gene variant associated with cancers
US Patent 7358230 Conserved diaphanous-related formin autoregulatory domain (DAD)
US Patent 7358353 Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
US Patent 7368551 None
US Patent 7371379 Dosages for treatment with anti-ErbB2 antibodies
US Patent 7371813 Method for use of IGF-binding protein for selective sensitization of target cells in vivo
US Patent 7374935 Human Rgr oncogene and truncated transcripts thereof detected in T cell malignancies, antibodies to the encoded polypeptides and methods of use
US Patent 7393823 HER-2 binding antagonists
US Patent 7396533 Polypeptides and nucleic acids encoding same
US Patent 7396810 Compositions and methods for treating cancer by modulating HER-2 and EGF receptors
US Patent 7402402 P38 MAPK pathway predicts endocrine-resistant growth of human breast cancer and provides a novel diagnostic and treatment target
US Patent 7405061 Antigen PIPA and antibodies that bind thereto
US Patent 7411042 Tumor associated nucleic acids and uses therefor
US Patent 7411055 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof
US Patent 7431932 Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions
US Patent 7435585 Auto-stimulating cells and methods for making and using the same
US Patent 7439234 Method for treating cancer patients undergoing chemotherapy
US Patent 7456268 Materials and methods for inhibiting Wip1
US Patent 7462491 Methods and compositions for diagnosis and monitoring of prostate cancer progression by detection of serum caveolin
US Patent 7465734 Methods and compositions for overcoming resistance to biologic and chemotherapy
US Patent 7482014 Melanoma therapy
US Patent 7485302 Treatment with anti-ErbB2 antibodies and chemotherapeutic agents
US Patent 7491807 Gene encoding a DNA repair enzyme and methods of use thereof
US Patent 7495074 Isolated proteins MAGE-4 and MAGE-41
US Patent 7498030 Treatment with anti-ErbB2 antibodies and anti-hormonal compounds
US Patent 7501122 Treatment with anti-ErbB2 antibody combinations
US Patent 7514076 Antitumor agents
US Patent 7537931 Humanized anti-ERBB2 antibodies and treatment with anti-ERBB2 antibodies
US Patent 7547441 PAI-2 conjugates for the treatment and imaging of cancer
US Patent 7550568 Monoclonal antibodies to human high molecular weight-melanoma associated antigen
US Patent 7556805 Compositions for treatment of melanoma and method of using same
US Patent 7560242 Metadherin polypeptides, encoding nucleic acids and methods of use
US Patent 7566542 Use of protein ASC as a marker for breast cancer
US Patent 7572798 Combi-molecules having signal transduction inhibitory properties and DNA damaging properties
US Patent 7575923 CD19xCD3 specific polypeptides and uses thereof
US Patent 7585509 Erb-2 receptor targeting peptide
US Patent 7598051 Compositions and methods for the therapy and diagnosis of ovarian cancer
US Patent 7605003 Use of biomarkers for detecting ovarian cancer
US Patent 7605246 Genes differentially expressed in breast cancer
US Patent 7608269 Compositions and methods for treating cancer by modulating HER-2 and EGF receptors
US Patent 7608696 IBC-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer
US Patent 7618631 Treatment with anti-ErbB2 antibodies and EGFR-targeted drugs
US Patent 7622306 Using plasma proteomic pattern for diagnosis, classification, prediction of response to therapy and clinical behavior, stratification of therapy, and monitoring disease in hematologic malignancies
US Patent 7625859 HER-2 binding antagonists
US Patent 7632486 Method for diagnosing bone metastasis of malignant tumor
US Patent 7635475 Diabody-type bispecific antibody
US Patent 7645441 Compositions and methods in cancer associated with altered expression of PRLR
US Patent 7648826 Detecting
US Patent 7655239 Immune reactivity to HER-2/
US Patent 7655411 Thrombospondin fragments and binding agents in the detection, diagnosis and evaluation of cancer
US Patent 7655472 Treatment of disease by inducing cell apoptosis
US Patent 7655631 Pharmaceutical preparations and methods for inhibiting tumors
US Patent 7666587 Method of screening test substances for treating or preventing a disease mediated by plasma cells
US Patent 7682612 Treatment of hematologic malignancies associated with circulating tumor cells using chimeric anti-CD20 antibody
US Patent 7687241 Methods and compositions for isolating metastatic cancer cells, and use in measuring metastatic potential of a cancer thereof
US Patent 7691976 BRAF35 protein and BRCA2/BRAF35 complex and methods of use
US Patent 7695962 Polypeptides and nucleic acids encoding same
US Patent 7700299 Method for predicting the response to a treatment
US Patent 7705120 Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
US Patent 7727528 Methods for diagnosis using anti-cytokine receptor antibodies
US Patent 7727534 Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions
US Patent 7732159 Assays for cancer patient monitoring based on levels of analyte components of the plasminogen activator system in body fluid samples
US Patent 7732588 Tweak receptor
US Patent 7744880 Cell growth inhibitors containing anti-glypican 3 antibody
US Patent 7754435 Prostate cancer-related compositions, methods, and kits based on DNA macroarray proteomics platforms
US Patent 7763461 Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyl transferase
US Patent 7767387 Therapeutic targets in cancer
US Patent 7767787 Substance for obtaining highly effective tumor medications as well as a process
US Patent 7771958 Method for predicting response to epidermal growth factor receptor-directed therapy
US Patent 7776518 Detection of survivin in the biological fluids of cancer patients
US Patent 7785810 Method and compositions for isolating metastatic cancer cells, and use in measuring metastatic potential of a cancer thereof
US Patent 7785841 Methods for the early diagnosis of ovarian cancer
US Patent 7790861 Prostate cancer-related compositions, methods, and kits based on DNA macroarray proteomics platforms
US Patent 7794723 Antigenic peptides derived from telomerase
US Patent 7794729 Methods and compositions for immunotherapy of cancer
US Patent 7794926 Detection of survivin in the biological fluids of cancer patients
US Patent 7799898 Human transferase family members and uses thereof
US Patent 7803909 Mutated Src oncogene composition and methods
US Patent 7820180 None
US Patent 7820447 Compositions and methods for cancer
US Patent 7824680 Methods for inhibiting angiogenesis
US Patent 7829297 Treatment of cancers expressing p95 ErbB2
US Patent 7829671 Gene encoding a DNA repair enzyme and methods of use thereof
US Patent 7834156 125P5C8: tissue specific protein highly expressed in various cancers
US Patent 7837995 Immunotherapy of B-cell malignancies using anti-CD22 antibodies
US Patent 7838007 Methods for treating mammary gland disorders
US Patent 7838008 Methods for treating diverse cancers
US Patent 7846441 Treatment with anti-ErbB2 antibodies
US Patent 7846456 Methods for breast treatment
US Patent 7858760 Antibodies to protein expressed in prostate cancer
US Patent 7863011 Screening method for predicting susceptibility to breast cancer
US Patent 7863424 Isolation of five novel genes coding for new Fc receptors-type melanoma involved in the pathogenesis of lymphoma/melanoma
US Patent 7867717 Immunoassays to detect diseases or disease susceptibility traits
US Patent 7879327 Medicament for treating cancer
US Patent 7883702 Use of anti-mortalin 2 antibody and functional nucleic acid for cancer therapies
US Patent 7887808 Human Rgr oncogene and truncated transcripts thereof detected in T cell malignancies, antibodies to the encoded polypeptides and methods of use
US Patent 7892542 Human anti-idiotypic antibody fragments that mimic HER-2/neu
US Patent 7892549 Treatment with anti-ErbB2 antibodies
US Patent 7892554 Internalizing ErbB2 antibodies
US Patent 7892730 Compositions and methods for cancer
US Patent 7893204 Attractin/mahogany-like polypeptides
US Patent 7906294 Prognosis and treatment of breast cancer
US Patent 7910103 Immunotherapy of B-cell malignancies using anti-CD22 antibodies
US Patent 7910551 Gene differentially expressed in breast and bladder cancer and encoded polypeptides
US Patent 7910704 Human p53 splice variant displaying differential transcriptional activity
US Patent 7927814 Antibody directed against gastrin-releasing peptide precursor and use thereof
US Patent 7932047 Method for detecting neoplastic disorders in a solubilized body sample
US Patent 7932360 Recombinant production of mixtures of antibodies
US Patent 7935350 Ii-key/Her-2/neu hybrid cancer vaccine
US Patent 7939073 Immunotherapy of B-cell malignancies using anti-CD22 antibodies
US Patent 7939080 HER-2 binding antagonists
US Patent 7939274 Prostate cancer-related compositions, methods and kits based on DNA macroarray proteomics platforms
US Patent 7939321 TADG-15: an extracellular serine protease overexpressed in carcinomas
US Patent 7947278 Methods of modulating angiogenesis
US Patent 7951917 Method for making multispecific antibodies having heteromultimeric and common components
US Patent 7960346 Tumor cytotoxicity induced by modulators of the CXCR4 receptor
US Patent 7960347 Matrix protein compositions for induction of apoptosis
US Patent 7977059 17867, a novel human aminopeptidase
US Patent 7981618 Diagnostic and therapeutic methods and compositions involving PTEN and breast cancer
US Patent 7981692 Immunoassays to detect diseases or disease susceptibility traits
US Patent 7985843 Compositions and methods for the therapy and diagnosis of ovarian cancer
US Patent 7998931 Vascular endothelial cell growth factor antagonists and uses thereof
US Patent 7998934 PAI-2 conjugates for the treatment and imaging of cancer
US Patent 7999072 Mutated netrin-4, fragments thereof and their use as medicines
US Patent 8003613 Methods and compositions for inducing apoptosis
US Patent 8007799 Vascular endothelial cell growth factor antagonists and uses thereof
US Patent 8012470 Method for ex vivo immunization using heterologous intact bispecific and/or trispecific antibodies
Edits on 13 Dec, 2021
Golden AI
edited on 13 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 8012470 Method for ex vivo immunization using heterologous intact bispecific and/or trispecific antibodies
Edits on 8 Dec, 2021
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 8007799 Vascular endothelial cell growth factor antagonists and uses thereof
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 8003613 Methods and compositions for inducing apoptosis
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7999072 Mutated netrin-4, fragments thereof and their use as medicines
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7998931 Vascular endothelial cell growth factor antagonists and uses thereof
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7998934 PAI-2 conjugates for the treatment and imaging of cancer
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7985843 Compositions and methods for the therapy and diagnosis of ovarian cancer
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7981692 Immunoassays to detect diseases or disease susceptibility traits
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7981618 Diagnostic and therapeutic methods and compositions involving PTEN and breast cancer
Golden AI
edited on 8 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7977059 17867, a novel human aminopeptidase
Edits on 7 Dec, 2021
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7960346 Tumor cytotoxicity induced by modulators of the CXCR4 receptor
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7960347 Matrix protein compositions for induction of apoptosis
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7951917 Method for making multispecific antibodies having heteromultimeric and common components
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7947278 Methods of modulating angiogenesis
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7939321 TADG-15: an extracellular serine protease overexpressed in carcinomas
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7939274 Prostate cancer-related compositions, methods and kits based on DNA macroarray proteomics platforms
Golden AI
edited on 7 Dec, 2021
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent primary examiner of
US Patent 7939080 HER-2 binding antagonists
Load more
Find more people like Alana M. Harris
Use the Golden Query Tool to discover related individuals, professionals, or experts with similar interests, expertise, or connections in the Knowledge Graph.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE